Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002075 · ClinicalTrials.gov registry record · NA
Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis
A NA study, sponsored by Pfizer.
- Completed
- Registry status
- NA
- Development phase
NCT00002075: Completed NA study, sponsored by Pfizer.
NCT00002075 is a NA study that has completed, run by Pfizer. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002075, a NA study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To compare the safety and effectiveness of fluconazole and amphotericin B, alone or in combination with flucytosine, as treatment for acute cryptococcal meningitis.
Interventions
- DRUG Fluconazole
- DRUG Amphotericin B
- DRUG Flucytosine
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
What the finished NCT00002075 record still lists
NCT00002075 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 3 interventions - of which Fluconazole is the first listed.
NCT00002075 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002075 about?
NCT00002075 is a clinical study titled "Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis". To compare the safety and effectiveness of fluconazole and amphotericin B, alone or in combination with flucytosine, as treatment for acute cryptococcal meningitis.
What is the current status of trial NCT00002075?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002075?
The interventions under investigation include: Fluconazole (DRUG), Amphotericin B (DRUG), Flucytosine (DRUG).
Who is sponsoring clinical trial NCT00002075?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.